Efficacy of an AFCN Proxy Block in Post-TKA Multimodal Pain Management

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-90
SponsorTaipei Medical University WanFang Hospital

About this trial

This randomized controlled trial evaluates the additive effect of Supra-Sartorial Subcutaneous Infiltration (SSSI) when performed in combination with intermittent adductor canal block (iACB) and posterior capsule local infiltration analgesia (PC-LIA) for pain management after total knee arthroplasty (TKA). SSSI, an easy-to-perform tentative proxy block to targeted anterior femoral cutaneous nerve (AFCN) block, is tested in 90 adults (45-90 years) randomized into two arms: active SSSI versus sham SSSI. Primary outcome is pain scores at rest and during movement on postoperative day 0; secondary outcomes include daily pain trajectory at rest and during movement, functional recovery scores, rescue analgesic doses over days 0-3, and quality of recovery assessment on day 4.

Eligibility criteria

Qualifiers

Adults aged 45-90 undergoing unilateral primary TKA for osteoarthritis.

American Society of Anesthesiologists (ASA) physical status I-III.

Able to provide informed consent and use NRS pain scales.

Surgery scheduled to start before noon to standardize spinal anesthesia recovery.

Disqualifiers

Bilateral or revision TKA.

Contraindications to regional anesthesia (e.g., coagulopathy, infection at injection site).

Chronic opioid use (>30 mg morphine equivalents/day) or preoperative NRS >4.

Pre-existing neurological deficits in lower extremities or AFCN-related neuropathy.

Trial design

Treatments tested in this trial

  • Supra-Sartorial Subcutaneous Infiltration (SSSI)
  • intermittent adductor canal block (iACB)
  • posterior capsule local infiltration analgesia (PC-LIA)

Treatment groups

90 Participants
are divided into 2 treatment groups